Pre-Conference

The Arizona Society of Addiction Medicine, American Osteopathic Academy of Addiction Medicine And PCSS-MAT present
2017 Buprenorphine Advanced Training and Office Based Opioid Treatment

Anthony Dekker, DO

Scottsdale Resort and Villas
6333 North Scottsdale Road
Scottsdale, AZ 85250
Friday November 17, 2017

AzSAM Members: $75
Non-Members: $100

REGISTER NOW

Anthony Dekker, DO and Monica G Faria, MD President AZSAM

TIME   TOPIC- SPEAKER
0730-0800 AM Registration & Pre-course Discussion and
Webinar Sign In Registration

8:00 A.M.     INTRODUCTION – Course Description – Dr. Dekker
8:15 A.M.     New Challenges for Buprenorphine in 2017 Updates from CSAT, DEA and RADARS – Dr. Dekker
8:45 A.M.     New Issues in Opioid and Buprenorphine Pharmacology – Dr. Faria
9:15 A.M.     Considerations in Patient Selection, Assessment – Dr. Dekker
9:45 A.M.     Special Cases for Discussion – Dr. Faria
10:15 A.M.   Q&A AND BREAK

Monica Faria, MD

10:30 A.M.   Challenges in Pain Medicine – Dr. Dekker
11:30 A.M.   DEA visits – Dr. Faria

12:00 P.M.    BREAK- FOLLOWED BY MANDATORY WEBINAR SIGN IN WAIVER APPLICATION FOR OBOT ATTENDEES – Dr. Dekker
12:30 PM    Special Populations and New Challenges of Buprenorphine including the Mother Study Dr. Dekker
1:15 P.M.    Psychiatric and Medical Complications in Addiction Dr. Faria
2:00 P.M.    Q&A AND BREAK
2:15 P.M.    Medical Record Keeping, Informed Consent, Confidentiality, Urine Testing and Office Security Dr. Faria
3:15 P.M.    Clinical Management with Buprenorphine Dr. Dekker
4:30 P.M.    Clinical Case Reviews and Program Evaluation
5:00 P.M.    MANDATORY SIGN OUT

This program qualifies as a DEA waiver eligibility granting program for physicians and is required for NPs and PACs in addition to 16 additional hours to qualify for the waiver.

Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (1U79TI026556) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.